 | • レポートコード：MRC2303M128 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| モルドールインテリジェンス社の本調査資料によると、酸素療法機器の世界市場にフォーカスし、最新動向と今後の市場性などをまとめており、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（酸素源装置、酸素供給装置）分析、用途別（喘息、閉塞性睡眠時無呼吸症候群、慢性閉塞性肺疾患、呼吸窮迫症候群、その他）分析、エンドユーザー別（病院、在宅医療、外来手術センター、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などが掲載されています。また、Allied Healthcare Products, Inc.、CAIRE Inc.、DeVilbiss Healthcare、Fisher & Paykel Healthcare Limited、Hersill、Invacare Corporation、Koninklijke Philips N.V.,、Smiths Medical、TECNO-GAZ SpA、Teleflex Incorporatedなど、主要企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の酸素療法機器市場規模：製品別 - 酸素源装置の市場規模 - 酸素供給装置の市場規模 ・世界の酸素療法機器市場規模：用途別 - 喘息における市場規模 - 閉塞性睡眠時無呼吸症候群における市場規模 - 慢性閉塞性肺疾患における市場規模 - 呼吸窮迫症候群における市場規模 - その他における市場規模 ・世界の酸素療法機器市場規模：エンドユーザー別 - 病院における市場規模 - 在宅医療における市場規模 - 外来手術センターにおける市場規模 - その他における市場規模 ・世界の酸素療法機器市場規模：地域別 - 北米の酸素療法機器市場規模 アメリカの酸素療法機器市場規模 カナダの酸素療法機器市場規模 メキシコの酸素療法機器市場規模 … - ヨーロッパの酸素療法機器市場規模 イギリスの酸素療法機器市場規模 フランスの酸素療法機器市場規模 ドイツの酸素療法機器市場規模 … - アジア太平洋の酸素療法機器市場規模 中国の酸素療法機器市場規模 インドの酸素療法機器市場規模 日本の酸素療法機器市場規模 … - 南米/中東の酸素療法機器市場規模 ブラジルの酸素療法機器市場規模 アルゼンチンの酸素療法機器市場規模 南アフリカの酸素療法機器市場規模 … - その他地域の酸素療法機器市場規模 ・競争状況 ・市場機会・将来の動向 |
The major factors for the growth of the oxygen therapy equipment market include the increase in tobacco smoking and the rising prevalence of respiratory diseases and technological advancement in oxygen therapy.
The increasing prevalence of respiratory diseases is the major factor expected to drive the overall growth of the market over the forecast period. As per the data published by the World Health Organization (WHO), the Global Burden of Disease Study reports a prevalence of 251 million cases of Chronic Obstructive Pulmonary Disease (COPD) globally in 2016. The cases of COPD is likely to increase globally owing to the higher smoking prevalence and aging populations in many countries.
Furthermore, as per the estimates of the American Academy of Allergy, Asthma & Immunology, in 2016, around 8.3% of children in the United States had asthma. It is the most common chronic disease in children. The major risk factor for most of the respiratory diseases is smoking. In 2016, more than 15 of every 100 US adults aged 18 years or older smoked cigarettes as per the estimates of Centre for Disease Control and Prevention (CDC). Thus, owing to the rising prevalence of respiratory diseases the market is expected to witness huge demand over the forecast period.
Oxygen Therapy Equipment Market Trends
Chronic Obstructive Pulmonary Disorder (COPD) is the Segment by Application expected to hold Largest Market Share over the Forecast Period
Chronic respiratory diseases affect the airways and other parts of the lungs for a long duration of the period. Respiratory symptoms are among the major causes of consultation with doctors and physicians in primary health care centers. Chronic respiratory diseases affect more than 1 billion people, globally, as per the Global Asthma report, 2018. COPD, with tobacco smoking as its root cause, has affected a significant part of the world population, as per the WHO. Furthermore, according to a 2017 publication in The Lancet Respiratory Medicine, in 2015, an estimated 3.2 people died from COPD, globally. If the patient has low levels of oxygen owing to COPD in blood then long-term oxygen therapy is used. Thus, the rising prevalence of COPD is expected to create huge demand for oxygen therapy equipments resulting in high growth of the Oxygen Therapy Equipment market.
North America is Expected to Hold Largest Market Share over the Forecast Period
The United States is expected to be the largest oxygen therapy equipment market owing to the rising prevalence of respiratory diseases and the presence of better healthcare infrastructure. Also, there is a rise in per capita health expenditure in the country which is expected to increase over the forecast period owing to the decrease in the unemployment rate. The major risk factor for most of the respiratory diseases is smoking. In 2016, more than 15 of every 100 US adults aged 18 years or older smoked cigarettes as per the estimates of the Centre for Disease Control and Prevention (CDC). The cases of COPD is likely to increase in the United States owing to the higher smoking prevalence and aging populations in the country. Over the last decades, there have been significant advances in oxygen concentrator design and functionality. The newer generation of portable oxygen concentrators is designed to be lightweight, quiet, and energy-efficient. Owing to associated advantages of compact size, lower cost, and convenience to carry, the use of portable oxygen contractors have been growing rapidly. Thus, owing to the all above mentioned factors the market is expected to witness high growth.
Oxygen Therapy Equipment Market Competitor Analysis
The market studied is a consolidated market owing to the presence of few major market players. Some of the market players are Allied Healthcare Products, Inc., CAIRE Inc., DeVilbiss Healthcare, Fisher & Paykel Healthcare Limited, Hersill, Invacare Corporation, Koninklijke Philips N.V., Smiths Medical, TECNO-GAZ SpA, and Teleflex Incorporated
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Tobacco Smoking and Rising Prevalence of Respiratory Diseases
4.2.2 Technological Advancement in Oxygen Therapy
4.3 Market Restraints
4.3.1 Stringent Regulatory Guidelines
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Oxygen Source Equipment
5.1.1.1 Oxygen Cylinders
5.1.1.2 Oxygen Concentrators
5.1.1.3 Liquid Oxygen Devices
5.1.1.4 Others
5.1.2 Oxygen Delivery Devices
5.1.2.1 Oxygen Masks
5.1.2.2 Nasal Cannula
5.1.2.3 Venturi Masks
5.1.2.4 Non-rebreather Masks
5.1.2.5 Others
5.2 By Application
5.2.1 Asthma
5.2.2 Obstructive Sleep Apnea
5.2.3 Chronic Obstructive Pulmonary Disorder (COPD)
5.2.4 Respiratory Distress Syndrome
5.2.5 Others
5.3 By End User
5.3.1 Hospitals
5.3.2 Home Healthcare
5.3.3 Ambulatory Surgical Centers
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allied Healthcare Products, Inc.
6.1.2 CAIRE Inc.
6.1.3 DeVilbiss Healthcare
6.1.4 Fisher & Paykel Healthcare Limited
6.1.5 Hersill
6.1.6 Invacare Corporation
6.1.7 Koninklijke Philips N.V.,
6.1.8 Smiths Medical
6.1.9 TECNO-GAZ SpA
6.1.10 Teleflex Incorporated
7 MARKET OPPORTUNITIES AND FUTURE TRENDS